Table 4. Case series of patients with surgical site infections.

No.	Age	ISS	DM	Pelvic binder	Pelvic EF	Time from PPP to second look (hours)	RBC transfusion (total)	Post-admission SSI identification timing	Organism	Mortality
1	51	38	X	O	O	57	8	5	MRSA	X
2	62	38	X	O	O	42	4	12	Staphylococcus aureus, Enterobacter aerogenes	X
3	79	38	X	X	O	72	8	6	Enterococcus faecalis, MDR AB (p)	O
4	70	35	O	X	X	48	11	8	Enterococcus caseliflavus	X
5	35	35	X	O	O	26	7		Escherichia coli	X

AB, Acinetobacter baumannii; DM, diabetes mellitus; EF, external fixation; MDR, multi-drug resistant; MRSA, methicillin-resistant Staphylococcus aureus; RBCs, red blood cells; SSI, surgical site infection